OK We use cookies to enhance your visit to our site and to bring you advertisements that might interest you. Read our Privacy and Cookies policies to find out more.

Clinical Implantology

Osstell President and CEO Jonas Ehinger, right, and Thaddeus Picklo, director of sales, are on hand at the company’s booth at the AAP in San Diego to show how to minimize risk and improve implant stability. (Photo: Sierra Rendon, DTA)
Nov 3, 2016 | Implantology USA

Q&A: How to improve implant stability

by Sierra Rendon, DTA

SAN DIEGO, Calif., USA: At the American Academy of Periodontology’s annual meeting in September, Dental Tribune had the opportunity to interview Osstell President and CEO Jonas Ehinger. Ehinger explains how Osstell’s technology helps clinicians determine when to load an implant.

Please tell us a little bit about Osstell’s company history. What do you believe sets Osstell apart from the other companies?
The company was created to help clinicians determine when to load an implant. This developed into an extensively researched and scientifically validated area of using Resonance Frequency Analysis (RFA) to assess osseointegration of implants by measuring implant stability. Today, there are more than 800 clinical publications on the topic, all featuring Osstell’s RFA equipment and Implant Stability Quotient (ISQ) technology. Scientific research and our goal to provide value for clinicians is in our DNA.

What do clinicians most need to know about your products/services? How can you help them?
To help practitioners enhance their confidence when performing implant procedures, they should be aware of Osstell IDX, an implant stability device that monitors osseointegration and informs the clinician of the optimal time to load an implant. The device is an extremely easy-to-use and cost-effective tool that will help clinicians choose surgical protocol and to know when to restore and load an implant. The device will also give clinicians early warnings of failing osseointegration and allow them to more predictably manage patients with risk factors.

What are some of your most popular products or products that you¹re most proud of?
Our latest products — the Osstell IDX and its cloud service, Osstell Connect (both sold exclusively by Henry Schein in the U.S. and Canada) — really set themselves apart from all the previous generations of Osstell products by putting actual measurements into a clinical context, based on the massive clinical validation and science that supports this diagnostic technology. Osstell Connect will allow clinicians to tailor and benchmark their treatment parameters to optimize their treatment for each patient.
More information about these products is available online, at www.henryschein.com/us-en/Dental/Supplies/Osstell.aspx.

Do you have any new products on the horizon that you can talk about?
There will be more interoperability with other systems to help facilitate a digital workflow when using ISQ technology. Other developments will include data sharing between units, users and clinicians to simplify information exchange among clinics. SmartPegs, delicate measurement devices, will also be more advanced, to enable more accurate and easily acquired measurements of implant and implant abutments.

What are some of Osstell’s most recent accomplishments?
Osstell is exploring partnerships with other device manufacturers to integrate Osstell ISQ as an add-on module to their devices. This would provide increased efficiency for the practitioner in measuring the stability of the implant-linked sequence conveniently with other relevant clinical procedures.

Where do you see the implant industry heading in the future, and do you foresee any challenges in helping customers adapt to those changes?
It is no surprise that the digitization of the industry is in full swing. Because of this fast-moving trend, which will only continue to evolve, it is our job to keep making products even easier to use and more intuitive, even if they are more advanced on the inside. Also, as new, more digitally-rooted clinicians enter the field, they will have advanced experiences, and expectations, about new, digital, technology and how to interact with it.

Where do you see Osstell at in the next five years?
Our products will interface with many other systems used in an implant clinic. Also, we expect that using simple and valuable diagnostic tools will be even more a norm than it is today. It is not far-fetched either to expect that Osstell ISQ technology will be available in other types of products used by clinicians who place dental implants — in order to both simplify and to make sure the clinicians have the information they need at their fingertips.

Is there anything else you¹d like for clinicians to know about Osstell or its products?
We see ourselves at the beginning of a new journey, during which we will aim for simplifying the use of our products even further, making them more and more intuitive. Diagnostics is about delivering peace of mind, helping to enhance user and patient confidence and comfort. All of this is what drives Osstell to continue to innovate.
 

Related Content
Print  |  Send to a friend